Evidence map›Paper›PMID 16420580›Full record

ArticleJournal of thrombosis and haemostasis : JTH2006

Function-blocking antithrombospondin-1 monoclonal antibodies.

D S Annis, J E Murphy-Ullrich, D F Mosher

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Thrombospondin-4 in tissue remodeling.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Review
  9. Article
  10. Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Article
  11. Article
  12. Article
  13. Thrombospondin-1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Thrombospondins function as regulators of angiogenesis.Journal of cell communication and signaling · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

D S AnnisDepartment of Medicine, University of Wisconsin, Madison, WI 53706, USA.
J E Murphy-Ullrich
D F Mosher
University of Wisconsin–Madison · USUniversity of Alabama · US

Funding

THROMBOSPONDIN &MAMMARY ENDOTHELIAL CELL PROLIFERATIONR01HL054462 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI MOSHER, DEANE FREMONT · 1995 to 2007
$3.1M
VOCATIONAL EVALUATION OF PATIENTS WITH RHEUMATOID ARTHRITISP60AR020614 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FESSLER, BARRI J · 1986 to 2001
$2.4M
REGULATION OF TGF-BETA ACTIVITY BY THROMBOSPONDINR01HL050061 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MURPHY-ULLRICH, JOANNE E · 1994 to 2004
$1.1M
EXTRAMURAL RESEARCH FACILITIES CONTRUCTIONC06RR015490 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GERRITY, LAURETTA W · 2000 to 2000
$1.0M
THROMBOSPONDIN AND TENASCIN--CELL ADHESION REGULATORSR01HL044575 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MURPHY-ULLRICH, JOANNE E · 1990 to 2000
$177k
NCRR NIH HHS C06 RR015490NCRR NIH HHS C06 RR 15490NHLBI NIH HHS HL054462NHLBI NIH HHS HL44575NHLBI NIH HHS R01 HL050061NHLBI NIH HHS R01 HL054462NIAMS NIH HHS P60 AR 20614
6 · The paper itself

Abstract

backgroundThrombospondin-1 (TSP-1) has been implicated in many different processes based in part on inhibitory activities of anti-TSP-1 monoclonal antibodies (mAbs).

objectiveTo map epitopes of 13 anti-TSP-1 mAbs to individual modules or groups of modules spanning TSP-1 and the closely related TSP-2 homolog.

resultsThe mapping has led to assignment or reassignment of the epitopes of four mAbs, refinement of the epitopes of six mAbs, and confirmation of the epitopes of the remaining three mAbs. ESTs10, P12, and MA-II map to the N-terminal domain; 5G11, TSP127.6, and ESTs12 to the third properdin module; C6.7, HB8432, and P10 to epidermal growth factor (EGF)-like modules 1 and/or 2; and A6.1, mAb133, MA-I, and D4.6 to the calcium-binding wire module. A6.1, which recognizes a region of the wire that is identical in mouse and human TSP-1, reacts with TSP-1 from both species, and also reacts weakly with human TSP-2. Two other mouse antihuman TSP-1 mAbs, A4.1 and D4.6, also react with mouse TSP-1.

conclusionsConsideration of previous literature and mapping of epitopes of inhibitory mAbs suggest that biological activities are present throughout TSP-1, including the EGF-like modules that have not been implicated in the past. Because the epitopes for 10 of the antibodies likely are within 18 nm of one another in calcium-replete TSP-1, some of the inhibitory effects may result from steric hindrance. Such seems to be the case for mAb133, which binds the calcium-binding wire but is still able to interfere with the activation of latent TGF-beta by the properdin modules.

Indexed as

Amino Acid SequenceAnimalsAntibodies, MonoclonalCattleCells, CulturedEndothelium, VascularEpitope MappingHumansMiceProtein Structure, TertiaryRatsRecombinant ProteinsThrombospondin 1Thrombospondin 2ThrombospondinsTransforming Growth Factor betaAntibodies, MonoclonalRecombinant ProteinsThrombospondin 1Thrombospondin 2ThrombospondinsTransforming Growth Factor beta

Identifiers

PMID16420580
PMCPMC2219891
OpenAlexW2060006380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.